About
Technology
Issues
FAQ
Links
Official Page
Cabozantinib (XL184), a Novel MET and VEGFR2 Inhibitor, Simultaneously Suppresses Metastasis, Angiogenesis, and Tumor Growth
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.